Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €537.00 | €568.09 | 5.790% |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| UCB S.A. | 2 | 0 | 0 | 0 | €122.25 | - | - |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.60 | €82.93 | 104.264% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €455.60 | €543.72 | 19.342% |
| United Therapeutics | 17 | 0 | 2 | 0 | €236.20 | €289.92 | 22.744% |
| Universal Health Services B | 9 | 3 | 1 | 1 | €154.00 | €159.70 | 3.704% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €94.50 | €108.77 | 15.099% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.46 | €5.00 | 12.108% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €187.00 | - | - |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.00 | - | - |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €375.25 | €382.71 | 1.987% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.94 | - | - |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €70.68 | €100.00 | 41.483% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €345.00 | - | - |
| Vitrolife AB | 3 | 0 | 0 | 0 | €14.48 | - | - |
| WAVE Life Sciences Ltd | 8 | 0 | 0 | 0 | €4.62 | €9.10 | 96.987% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €342.70 | €369.72 | 7.886% |
| X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.06 | €2.78 | 163.118% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €23.00 | €68.78 | 199.040% |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | €154.96 | €200.06 | 29.103% |